Articles tagged "Kidney transplantation"

2016 American Transplant Congress
Cold Ischemia Induced Outcomes in Kidney Transplantation: A Meta-Analysis.
D. Bennett, M. Mustafa, M. Chiles, W. Skillen, S. Mohan.
Columbia University Medical Center, New York, NY.
Objective: To examine the association between cold ischemia time (CIT) and delayed graft function (DGF) and death-censored graft failure in kidney transplantation.Methods: To identify relevant…
2016 American Transplant Congress
Diabetes Mellitus Predicts Outcome in Obesity After Kidney Transplantation.
T. Schachtner,^1,2 M. Stein,² P. Reinke.^1,2
¹Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany; ²Berlin-Brandenburg Center for Regenerative Therapies, Charite Campus Virchow Clinic, Berlin, Germany.
Obesity has been associated with an increased risk of allograft loss and death from infection in kidney transplant recipients (KTRs). Therefore, previous studies suggested bariatric…
2016 American Transplant Congress
Watch Out for the Guy with the Low EPTS Score: Nonadherence and Kidney Allograft Failure.
A. Liu, K. Balabhadrapatruni, J. Augustine.
Medicine, University Hospitals Case Medical School, Cleveland, OH.
Background: Nonadherence is a known cause of rejection and kidney allograft failure. Our aim was to define risk factors for allograft loss related to nonadherence.…
2016 American Transplant Congress
Increasing Volume and Improved Survival in Solid Organ Transplantation for Amyloidosis – An Analysis of the UNOS Database.
J. Jaramillo,¹ J. Stehlik,¹ J. Fang,¹ R. Al-Dulaimi,¹ E. Gilbert,¹ S. Drakos,¹ O. Wever-Pinzon,¹ C. Selzman,¹ S. McKellar,¹ T. Kovacsovics,² J. Abraham,² M. Maurer,³ J. Nativi-Nicolau.¹
¹University of Utah, Salt Lake City, UT; ²Huntsman Cancer Institute, Salt Lake City, UT; ³New York-Presbyterian/Columbia University, New York, NY.
Background: Amyloidosis is a rare disease that results from accumulation of inappropriately folded proteins causing organ failure and poor prognosis. In the last decade several…
2016 American Transplant Congress
How Tacrolimus Variability Affects Donor Specific Antibodies, Rejection and Outcome After Kidney Transplantation.
S. Papachristos, A. John Velvet, A. Summers, A. Tavakoli, R. Dhanda, R. Pararajasingam, B. Forgacs.
Manchester Transplantation Unit, Manchester Royal Infirmary Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.
Purpose:To investigate the effect of tacrolimus(tac) variability on the development of Donor Specific Antibodies(DSA),rejection and outcome in relation to Age, Gender, Ethnicity and Body Mass…
2016 American Transplant Congress
Survival Benefit from Kidney Transplantation Using Kidneys from Deceased Donors Over 75 Years.
M. Pérez-Sáez,¹ E. Arcos,² J. Comas,² M. Crespo,¹ J. Lloveras,¹ J. Tort,² J. Pascual,¹ Catalan Renal Registry Committee.²
¹Nephrology, Hospital del Mar, Barcelona, Spain; ²Catalan Renal Registry, Organització Catalana de Trasplantaments, Barcelona, Spain.
Large registries have shown that end-stage renal disease patients have longer survival after kidney transplantation (KT) than remaining on dialysis. However, the outcome for kidneys…
2016 American Transplant Congress
15-Years Experience with the EUROTRANSPLANT Senior Program.
H.-M. Tautenhahn,¹ S. Brückner,¹ H.-M. Hau,¹ H. Morgül,¹ J. Broschewitz,¹ C. Pipiale,¹ F. Pankow,¹ S. Erler,² M. Bartels.¹
¹Universitätsklinikum Leipzig, Leipzig, Germany; ²Martin-Luther-Universität Halle, Halle, Germany.
Introduction: The ESP (Eurotransplant senior program), introduced in 1999 by EUROTRANSPLANT, is supposed to shorten the waiting period for elder recipients. The aim of this…
2016 American Transplant Congress
Incidence of Post-Transplant Lymphoproliferative Disorder in First, Kidney-Only Transplant Recipients Remains Stable.
J. Molony,¹ Y. Peng,¹ N. Baker,² U. Meier-Kriesche,³ J. Snyder.¹
¹Chronic Disease Research Group, Minneapolis; ²Brystol-Myers Squibb Company (BMS), Hopewell; ³BMS, Lawrenceville.
We estimated the incidence of and risk factors for post-transplant (TX) lymphoproliferative disorder (PTLD) in the 3 years post-TX for adults with first, kidney-only TX…
2016 American Transplant Congress
Glomerular Capillary C4d Staining without Evidence of Rejection Is Associated with Worse Graft Function in ABO-Incompatible Kidney Transplantation.
D. Toki,¹ M. Inui,¹ M. Okumi,² H. Ishida,² K. Setoguchi,¹ T. Shimizu,² K. Unagami,² K. Tanabe.²
¹Urology, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan; ²Urology, Tokyo Women's Medical University, Tokyo, Japan.
Objectives: C4d staining in the peritubular capillaries (C4d-PTC) is often observed without evidence of rejection in ABO-incompatible kidney transplantation (ABOI-KTx), and this phenomenon is generally…
2016 American Transplant Congress
Induction Therapy in Low Risk African American Kidney Transplant Recipients: Donor Factors.
F. Al Ammary,¹ S. Bae,¹ A. Massie,¹ N. Dagher,¹ E. King,¹ A. Wiseman,² D. Segev.¹
¹JHU, Baltimore; ²CU, Denver.
African Americans (AA) are at a higher risk of acute rejection and graft loss compared to non-AA kidney transplant (KT) recipients. Guidelines specify induction choices…